Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Nov 10, 2021 · 10-Q · 41 days after period end · 0001564590-21-056229
| Metric | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|
| Revenue | $666.00K | — | — |
| Net Income | -$60.83M | -$36.08M | -$19.67M |
| EPS Diluted | -$0.66 | -$3.00 | -$5.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end
